Top Story

Management of localized prostate cancer has improved in community-based practices

Management of localized prostate cancer has improved in community-based practices
July 7, 2015

The use of active surveillance and watchful waiting for patients with low-risk prostate cancer significantly increased since 2010 in community-based practices, according to study findings.

Further, high-risk disease was treated more frequently with curative local treatment rather than androgen deprivation therapy alone, results also showed.

FDA News

FDA grants orphan drug designation to BLZ-100 for brain cancer

July 7, 2015
The FDA granted orphan drug designation to BLZ-100, an agent intended to improve surgery for malignant brain tumors by providing real-time, high-resolution visualization…
Meeting News Coverage

No overall improvement in mCRC PFS with Y-90 spheres, but liver-only metastases respond well

July 7, 2015
Radiation therapy using yttrium-90 resin microspheres combined with chemotherapy did not improve overall progression-free survival in patients with nonresectable…
Elisa V. Bandera, MD In the Journals

BMI should not influence chemotherapy dose reductions for ovarian cancer

July 7, 2015
Women with ovarian cancer who received paclitaxel and carboplatin dose reductions experienced poorer survival regardless of their body size, according to study…
In the Journals

Extended anticoagulation beneficial after pulmonary embolism; stops when treatment ends

July 7, 2015
Patients who experience a first pulmonary embolism may benefit from anticoagulation therapy for up to 2 years after the unprovoked episode, although the benefits of…
More News Headlines »
Tailored Therapies for Myelodysplastic Syndromes

Tailored Therapies for Myelodysplastic Syndromes

This activity is supported by an educational grant from Celgene Corporation.

Myelodysplastic syndromes (MDS) represent a group of myeloid clonal hemopathies with heterogeneous clinical…
More »
Meeting News Coverage Video
VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

VIDEO: Complete lymph node dissection does not improve outcomes in SLNB-positive melanoma

June 19, 2015
CHICAGO — Vernon K. Sondak, MD, chair of the department of cutaneous oncology at Moffitt Cancer Center and a…
More »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
morganatic-roan
morganatic-roan